bsdc1 Antibody

What is the target epitope specificity of BSDC1 antibody?

The BSDC1 antibody (ABIN203469) specifically recognizes a synthetic peptide located between amino acids 84-133 of human BSDC1 (Q9NW68-3, NP_060515) . This epitope demonstrates remarkable evolutionary conservation, with 100% sequence identity across numerous mammalian species including humans, chimpanzees, mice, and bovines . The high conservation suggests this region may be functionally significant in the BSDC1 protein. When designing experiments, researchers should consider that this antibody targets a specific region, which may influence detection capability depending on protein conformation or post-translational modifications.

What species reactivity can researchers expect from BSDC1 antibody?

The BSDC1 antibody (ABIN203469) exhibits extensive cross-species reactivity due to the high conservation of its target epitope. According to specifications, it demonstrates confirmed reactivity with human, mouse, cow, guinea pig, horse, rabbit, hamster, monkey, and pig samples . BLAST analysis predicts additional reactivity with chimpanzees, gorillas, gibbons, galagos, marmosets, elephants, and pandas at 100% identity; dogs, bats, and platypus at 92% identity; and Xenopus at 85% identity . This broad cross-reactivity makes this antibody particularly valuable for comparative studies across multiple model organisms and evolutionary research.

What applications is the BSDC1 antibody validated for?

The BSDC1 antibody (ABIN203469) has been validated for several common immunological applications, including:

• Western Blotting (WB)

• Immunohistochemistry (IHC)

• Immunohistochemistry on Paraffin-embedded Sections (IHC-P)

This versatility allows researchers to use this antibody for both protein expression quantification and subcellular localization studies. The antibody's functionality across these diverse applications suggests that the epitope it recognizes remains accessible under various sample preparation conditions, including denaturation (for WB) and fixation/embedding (for IHC-P).

What are the physical and chemical properties of this antibody preparation?

The BSDC1 antibody (ABIN203469) is a rabbit polyclonal antibody of the IgG isotype . It is supplied in an unconjugated format, allowing researchers flexibility in selecting secondary detection systems appropriate for their specific experimental setup . The antibody has undergone Protein A purification, ensuring removal of non-specific immunoglobulins and enhanced specificity . The polyclonal nature of this antibody means it recognizes multiple epitopes within the target region (aa 84-133), which can enhance signal strength but may introduce batch-to-batch variability that researchers should control for in experimental design.

How does epitope conservation impact experimental design across species?

The exceptional conservation of the BSDC1 epitope (aa 84-133) across species has significant implications for experimental design in comparative biology studies. With 100% identity across most mammals and high conservation even in amphibians (85% in Xenopus) , researchers can confidently use this antibody for cross-species analysis of BSDC1 expression and localization patterns. This conservation profile suggests:

• Potential for direct comparison of BSDC1 expression across multiple model organisms

• Ability to detect orthologous proteins in evolutionary studies

• Opportunity to validate findings across species

What considerations should guide selection between different BSDC1 antibodies?

When selecting between BSDC1 antibodies targeting different epitopes, researchers should consider several experimental factors:

Available BSDC1 antibodies target diverse regions including aa 84-133, N-terminal regions, aa 238-287, aa 380-430, and C-terminal regions (aa 397-425) , providing researchers with options to address these various considerations.

How can researchers address reproducibility challenges with polyclonal BSDC1 antibodies?

The polyclonal nature of available BSDC1 antibodies presents specific reproducibility considerations that researchers must address methodologically:

• Lot consistency management: Document lot numbers and preferentially use the same lot for comparative studies to minimize batch-to-batch variation inherent to polyclonal antibodies.

• Validation protocol implementation: Establish a consistent validation protocol including:

  • Western blot confirmation of specific band at expected molecular weight

  • Positive and negative control tissues with known BSDC1 expression

  • Peptide competition assays to confirm specificity

• Quantitative normalization strategies: When performing quantitative analyses:

  • Include technical and biological replicates

  • Normalize to appropriate housekeeping controls

  • Establish consistent threshold criteria for positive detection

• Detailed methodological documentation: Report comprehensive antibody details in publications, including catalog number, lot, concentration, incubation conditions, and optimization parameters.

These methodological approaches can substantially mitigate reproducibility challenges associated with polyclonal antibodies.

What advanced validation strategies confirm BSDC1 antibody specificity?

For rigorous BSDC1 antibody validation, researchers should implement a multi-tiered approach:

• Molecular validation:

  • Peptide competition assays using the immunizing peptide (aa 84-133)

  • Comparison of detection patterns with antibodies targeting different BSDC1 epitopes

  • Expression correlation with BSDC1 mRNA levels across tissues

• Genetic approaches:

  • Testing on BSDC1 knockdown/knockout samples

  • Validation with overexpressed tagged BSDC1 constructs

  • Mutation analysis of key residues within the epitope

• Biochemical characterization:

  • Immunoprecipitation followed by mass spectrometry identification

  • Size exclusion chromatography to confirm complex formation

  • Phosphatase treatment to assess phosphorylation-dependent recognition

What is the optimal Western blotting protocol for BSDC1 detection?

While the search results don't provide a BSDC1-specific Western blotting protocol, the following methodological approach is recommended based on standard immunoblotting principles:

• Sample preparation optimization:

  • Extract proteins using RIPA buffer supplemented with protease/phosphatase inhibitors

  • Determine protein concentration via BCA or Bradford assay

  • Denature samples at 95°C for 5 minutes in Laemmli buffer containing β-mercaptoethanol

• Electrophoresis and transfer parameters:

  • Separate 20-40 μg protein on 10-12% SDS-PAGE gel

  • Transfer to PVDF membrane at 100V for 1 hour or 30V overnight at 4°C

  • Verify transfer efficiency with reversible membrane staining

• Antibody incubation conditions:

  • Block membrane in 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with BSDC1 antibody (1:500-1:1000 dilution) overnight at 4°C

  • Wash extensively (3×10 minutes) with TBST

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000-1:10000)

• Detection and quantification approach:

  • Develop using enhanced chemiluminescence substrate

  • Capture images within linear range of detection

  • Quantify band intensity relative to loading control (β-actin or GAPDH)

This protocol should be optimized for specific sample types and experimental conditions.

How should researchers optimize BSDC1 antibody for immunohistochemistry?

For optimal immunohistochemical detection of BSDC1, researchers should methodically optimize several parameters:

• Tissue fixation and processing:

  • Fix tissues in 10% neutral-buffered formalin for 24-48 hours

  • Process and embed in paraffin using standard protocols

  • Section at 4-5 μm thickness on positively charged slides

• Antigen retrieval optimization:

  • Test both heat-induced epitope retrieval methods:

    • Citrate buffer (pH 6.0)

    • EDTA buffer (pH 9.0)

  • Determine optimal retrieval duration (10-30 minutes)

• Antibody titration and incubation:

  • Perform serial dilutions (1:100, 1:200, 1:500, 1:1000)

  • Compare overnight incubation at 4°C versus 1-2 hours at room temperature

  • Optimize secondary detection system (polymer-based versus avidin-biotin)

• Signal development and counterstaining:

  • Titrate DAB development time for optimal signal-to-noise ratio

  • Select appropriate counterstain based on expected subcellular localization

  • Consider automated staining platforms for consistency in multi-sample studies

• Controls implementation:

  • Include positive control tissue with known BSDC1 expression

  • Incorporate negative controls (antibody diluent only)

  • Use isotype control to assess non-specific binding

This systematic optimization approach ensures reliable, reproducible BSDC1 detection in tissue sections.

What quantitative methods are appropriate for BSDC1 expression analysis?

For quantitative analysis of BSDC1 expression using antibody-based methods, researchers should consider these methodological approaches:

• Western blot densitometry:

  • Ensure detection within linear range by testing serial dilutions

  • Normalize BSDC1 signal to appropriate loading controls

  • Use image analysis software with background subtraction capabilities

  • Implement statistical analysis across biological replicates

• Immunohistochemistry quantification:

  • Develop standardized scoring system based on:

    • Staining intensity (0-3+ scale)

    • Percentage of positive cells

    • H-score calculation (intensity × percentage)

  • Consider digital pathology approaches for unbiased quantification

  • Validate scoring consistency across multiple observers

• Flow cytometry analysis:

  • Optimize fixation and permeabilization for intracellular BSDC1 detection

  • Use median fluorescence intensity for quantitative comparisons

  • Implement appropriate gating strategies for cell subpopulation analysis

  • Calculate fold change relative to control samples

These methodological approaches provide options for reliable quantitative analysis of BSDC1 expression across different experimental platforms.

How can multiplexed detection enhance BSDC1 localization studies?

Multiplexed detection strategies can provide valuable contextual information about BSDC1 subcellular localization and interaction partners:

• Immunofluorescence co-localization analysis:

  • Pair BSDC1 antibody with markers for specific cellular compartments:

    • Nuclear envelope (Lamin B1)

    • Endoplasmic reticulum (Calnexin)

    • Golgi apparatus (GM130)

    • Mitochondria (TOMM20)

  • Implement appropriate spectral separation for fluorophores

  • Quantify co-localization using Pearson's or Mander's coefficients

• Proximity ligation assay (PLA) approach:

  • Combine BSDC1 antibody with antibodies against potential interaction partners

  • Analyze PLA signals as indicators of protein proximity (<40nm)

  • Quantify interaction events per cell as measure of association strength

• Sequential immunohistochemistry methodology:

  • Perform iterative staining-imaging-stripping cycles

  • Align images using computational registration

  • Analyze co-expression patterns across multiple markers

These advanced methodological approaches enable researchers to contextualize BSDC1 expression within the cellular microenvironment and functional interaction networks.

What strategies address non-specific binding in BSDC1 immunodetection?

When encountering non-specific binding with BSDC1 antibody, researchers should implement these methodological solutions:

• Blocking optimization:

  • Test alternative blocking agents:

    • BSA (1-5%)

    • Normal serum (5-10%)

    • Commercial blocking solutions

  • Extend blocking duration (1-2 hours)

  • Consider addition of 0.1-0.3% Triton X-100 to reduce hydrophobic interactions

• Antibody dilution refinement:

  • Perform systematic titration series

  • Increase washing duration and stringency

  • Consider overnight incubation at 4°C to enhance specific binding

• Sample-specific approaches:

  • For tissues with high endogenous peroxidase: implement quenching steps

  • For high background tissues: pre-incubate antibody with control lysate

  • For cross-reactivity concerns: perform peptide competition controls

These methodological refinements can substantially improve signal-to-noise ratio in BSDC1 detection.

How do fixation parameters impact BSDC1 epitope accessibility?

Different fixation methods can significantly impact BSDC1 epitope accessibility, requiring methodological optimization:

Researchers should systematically compare these fixation methods to determine optimal conditions for BSDC1 detection in their specific sample type.

How does BSDC1 antibody compare to other BSD domain protein detection methods?

The BSDC1 antibody provides specific advantages compared to other methods for detecting BSD domain-containing proteins:

• Specificity comparison:

  • The antibody specifically targets BSDC1 without cross-reactivity to other BSD domain proteins

  • Alternative methods like generic BSD domain antibodies may not distinguish between family members

  • RNA-based detection methods (RT-PCR, RNA-seq) provide transcript but not protein information

• Application versatility:

  • BSDC1 antibody enables protein-level detection across multiple applications (WB, IHC, IHC-P)

  • Alternative approaches like mass spectrometry offer higher specificity but lower sensitivity

  • In situ hybridization provides spatial information but at RNA rather than protein level

• Cross-species applicability:

  • The remarkable conservation of the target epitope (aa 84-133) enables comparative studies across diverse species

  • Tagged constructs require transgenic approaches limiting in vivo and clinical sample applications

  • Computational predictions lack experimental validation

This comparative analysis highlights the unique research utility of BSDC1-specific antibodies in protein-level studies across diverse species.

What research questions can BSDC1 antibody help address?

The BSDC1 antibody enables investigation of numerous research questions including:

• Expression pattern analysis:

  • How does BSDC1 expression vary across tissues and cell types?

  • Is BSDC1 expression altered in disease states or developmental processes?

  • Does BSDC1 show subcellular compartmentalization?

• Evolutionary conservation studies:

  • How conserved is BSDC1 expression pattern across species?

  • Does BSDC1 localization differ between evolutionary distant organisms?

  • Are there species-specific post-translational modifications?

• Functional investigation:

  • Does BSDC1 co-localize with specific cellular structures?

  • How does BSDC1 expression respond to cellular stressors or signaling events?

  • Is BSDC1 expression correlated with specific cellular phenotypes?

The broad reactivity and application versatility of this antibody make it particularly valuable for addressing these research questions.